None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Receiving enoxaparin Being aware according MMSE Being hospitalized at least for 3 days Having informed consent Non-injecting drug or other anticoagulant in the abdomen wall Not having cold skin allergy Normal PT, PTT, INR and platelets
Exclusion criteria
Exclusion criteria: Discharge earlier than 3 days Skin allergy to the cold pack during intervention Reluctance to continue cooperation Bleeding from the injection site Decreased consciousness in the study process
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The complications of Enoxaparin injection. Timepoint: During, 24, 48 and 72 hours after injection. Method of measurement: The using of the Visual Analogue Scale and Transparent millimeter ruler. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Score of the patients' pain. Timepoint: The measurement of pain during injection. Method of measurement: According to Visual Analogue Scale.;The measurement of Bruising size. Timepoint: 24, 48 and 72 hours after Enoxaparin injection. Method of measurement: Transparent millimeter ruler. | — |
Countries
Iran (Islamic Republic of)
Contacts
Rasht University of Medical Sciences